ROBERTSON GLOBAL HEALTH SOLUTIONS CORP - FORM 10-Q - EX-10.17 - EXHIBIT 10.17 - August 16, 2010

Attached files

file filename
10-Q - FORM 10-Q - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPc04838e10vq.htm
EX-32 - EXHIBIT 32 - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPc04838exv32.htm
EX-4.4 - EXHIBIT 4.4 - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPc04838exv4w4.htm
EX-4.1 - EXHIBIT 4.1 - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPc04838exv4w1.htm
EX-4.3 - EXHIBIT 4.3 - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPc04838exv4w3.htm
EX-4.2 - EXHIBIT 4.2 - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPc04838exv4w2.htm
EX-10.8 - EXHIBIT 10.8 - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPc04838exv10w8.htm
EX-10.4 - EXHIBIT 10.4 - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPc04838exv10w4.htm
EX-10.5 - EXHIBIT 10.5 - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPc04838exv10w5.htm
EX-10.6 - EXHIBIT 10.6 - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPc04838exv10w6.htm
EX-10.9 - EXHIBIT 10.9 - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPc04838exv10w9.htm
EX-10.2 - EXHIBIT 10.2 - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPc04838exv10w2.htm
EX-10.1 - EXHIBIT 10.1 - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPc04838exv10w1.htm
EX-21.1 - EXHIBIT 21.1 - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPc04838exv21w1.htm
EX-10.7 - EXHIBIT 10.7 - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPc04838exv10w7.htm
EX-31.1 - EXHIBIT 31.1 - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPc04838exv31w1.htm
EX-10.3 - EXHIBIT 10.3 - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPc04838exv10w3.htm
EX-31.2 - EXHIBIT 31.2 - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPc04838exv31w2.htm
EX-10.15 - EXHIBIT 10.15 - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPc04838exv10w15.htm
EX-10.16 - EXHIBIT 10.16 - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPc04838exv10w16.htm
EX-10.13 - EXHIBIT 10.13 - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPc04838exv10w13.htm
EX-10.14 - EXHIBIT 10.14 - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPc04838exv10w14.htm
EX-10.19 - EXHIBIT 10.19 - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPc04838exv10w19.htm
EX-10.18 - EXHIBIT 10.18 - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPc04838exv10w18.htm
EX-10.20 - EXHIBIT 10.20 - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPc04838exv10w20.htm
EX-10.10 - EXHIBIT 10.10 - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPc04838exv10w10.htm
EX-3.1 - EXHIBIT 3.1 - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPc04838exv3w1.htm
EX-10.11 - EXHIBIT 10.11 - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPc04838exv10w11.htm
Exhibit 10.17
Addendum to Robertson Technologies Licensing, LLC And
Aversien Science, L.L.C. Product Distribution Agreement
As of 03/29/2010, the contract entitled Robertson Technologies Licensing, LLC And Aversien Science, L.L.C. Product Distribution Agreement between Robertson Technologies Licensing, LLC and Aversien Science, L.L.C. will be supplemented as follows:
XVII (COMMISSIONS) will be added as follows:
The following payment agreement is from the Robertson Technologies Licensing, LLC (RTL) and Companies On Text (COT) Licensing Agreement.
1. License Fees. In consideration for the license and other rights granted to Licensee, Licensee will pay Licensor license fees as follows:
  a.   Eight Dollars ($8.00) per pre-paid card distributed through licensee. License is for a one (1) year usage and is renewable annually at the same Eight Dollar ($8.00) rate. However, Licensor and Aversien Science reserve the right to adjust pricing according to business and market conditions at the end of three-year contract from date of contract execution.
  b.   Platform Setup fees of Two Hundred Fifty Thousand Dollars ($250,000) upon execution of this Agreement to be held in escrow payable from date of contract execution when product is completed and proof of concept with pre-paid card, major wireless phone and internet carriers is also completed.
  c.   Advance license fees of Seven Hundred Fifty Thousand Dollars ($750,000) on or before 30 days following execution of this Agreement payable from date of contract execution when product is completed and proof of concept with pre-paid card and major wireless phone and internet carrier is also completed.
  d.   Licensor will make available Ninety Three Thousand Seven Hundred and Fifty (93,750) licenses for use either through mobile or internet upon completion of product and proof of concept.
The below commission is an addendum to the above mentioned agreement that references the payment structure for each sales opportunity Aversien Science presents. Aversien Science will receive compensation (outlined below) for the sales from the licensing agreement between Robertson Technologies Licensing, LLC and Companies On Text.
Aversien Science, L.L.C. and Robertson Technologies Licensing, LLC agree on payments for this contract as follows.
The remaining $750,000 due RTL on or before 30 days of execution of the Robertson Technologies Licensing, LLC (RTL) and Companies On Text (COT) Licensing Agreement will follow as outlined below.
Robertson Technologies Licensing will receive Two Dollars and fifty cents ($2.50) per license sold. Aversien Science will receive Six Dollars ($5.50) per license sold

 

 

 

This totals the Eight Dollars ($8.00) RTL receives from COT for each license sold
Payment is due Aversien Science upon COT’s payments clearing in RTL’s bank account and no later than seven (7) days after the same.
These changes are the only changes to the original contract. The entire remainder of the original contract remains in full force.
Signed and Agreed:
     
Representative of Robertson Technologies Licensing, LLC
    
 
    
/s/ Joel C. Robertson
 
   Date: 5/10/10 
Name: Joel Robertson
    
Title: CEO
    
 
    
Representative of Aversien Science, L.L.C.
    
 
    
/s/ Herbert Gibson
 
   Date:                      
Name: Herbert Gibson
    
Title: CEO
    

 

 

Stock widget

Investing forum

ROBERTSON GLOBAL HEALTH SOLUTIONS CORP Reports